InsiderClue
← All stocks

ANI PHARMACEUTICALS INC

ANIP Net selling
CIK 0001023024 #2131 in the set updated 17 Sep 2026
Bought (120 mo)
$2.23M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$178.54M
$55.52M on a plan · $15.61M straight out of an exercise
Sold at will
$107.41M
89 of 238 sales
Net
−$176.31M
−$105.18M against sales at will

By person

26 insiders · 264 transactions
28.7×

Nikhil Lalwani holds 28.7 times base salary in stock. $24.08M of shares against $837.41K in salary for 2025.

Salary from the company's own proxy. The shares are what Nikhil Lalwani last reported holding, valued at $71.00, the price Common Stock was last bought or sold at on the open market here, on 15 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
$276.50K (2)
$58.70M (60) scheduled
−$58.43M
532,976
2.37%
$37.84M
—
MERIDIAN VENTURE PARTNERS II LP entity
10% owner
—
$28.62M (10)
−$28.62M
1,819,259
8.09%
$129.17M
−22.6%
Lalwani Nikhil
PRESIDENT & CEO
$200.00K (1)
$19.96M (11)
−$19.76M
339,089
1.51%
$24.08M
—
Gassert Chad
SVP - CORP. DEV. & STRATEGY
$275.09K (2)
$15.14M (13) scheduled
−$14.87M
233,406
1.04%
$16.57M
—
MARSHBANKS TRACY
Director
—
$12.49M (11)
−$12.49M
361,044
1.61%
$25.63M
−35.5%
CAREY STEPHEN P.
SVP & CFO
—
$8.41M (12) scheduled
−$8.41M
171,843
0.7640%
$12.20M
—
PRZYBYL ARTHUR
President and CEO
—
$7.80M (11)
−$7.80M
190,309
0.8461%
$13.51M
−12.1%
Marken James G.
SVP OPS & PROD DEV
—
$3.77M (7)
−$3.77M
117,829
0.5239%
$8.37M
+142.2%
Mutz Christopher
HEAD OF RARE DISEASE
—
$2.86M (11) scheduled
−$2.86M
91,309
0.4060%
$6.48M
—
Schrepfer Robert W
SVP - NEW BUS DEV & SPEC SALES
—
$2.70M (8) scheduled
−$2.70M
87,477
0.3889%
$6.21M
+403.8%
Gutwerg Ori
SVP, GENERICS
—
$2.68M (10)
−$2.68M
75,534
0.3358%
$5.36M
—
Walsh Patrick D
Director
$707.94K (6)
$3.12M (5)
−$2.42M
38,432
0.1709%
$2.73M
—
RAYNOR DANIEL
Director
—
$2.18M (6)
−$2.18M
300,113
1.33%
$21.31M
−10.2%
Thoma Jeanne
Director
$49.82K (1)
$1.99M (3)
−$1.94M
26,762
0.1190%
$1.90M
+1,684%
Pera Antonio R
Director
$126.79K (1)
$1.82M (4)
−$1.69M
27,017
0.1201%
$1.92M
—
Davis Krista
SVP, CHIEF HR OFFICER
—
$1.62M (12) scheduled
−$1.62M
51,946
0.2310%
$3.69M
—
HAUGHEY THOMAS
Director
$497.20K (4)
$1.82M (2)
−$1.33M
38,878
0.1729%
$2.76M
—
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
—
$911.39K (35) scheduled
−$911.39K
73,924
0.3287%
$5.25M
—
Leonard Matthew J
Director
—
$840.72K (2)
−$840.72K
11,221
0.0499%
$796.69K
—
Rowland Thomas Andrew
SVP, HEAD - ESTABLISHED BRANDS
—
$820.24K (3)
−$820.24K
38,271
0.1702%
$2.72M
+9.6%
TANNENBAUM RENEE P
Director
—
$273.81K (2)
−$273.81K
29,514
0.1312%
$2.10M
—
NASH DAVID
Director
$99.36K (1)
—
+$99.36K
38,561
0.1714%
$2.74M
—
Brown Robert E. JR
Director
—
—
—
49,021
0.2180%
$3.48M
+384.9%
HOLUBOW FRED
Director
—
—
—
14,811
0.0659%
$1.05M
+25.4%
Penn Thomas A.
Director
—
—
—
14,301
0.0636%
$1.02M
+41.5%
Gosebruch Henry O
Director
—
—
—
6,662
0.0296%
$473.00K
—

Individual transactions

86
Insider
Date
Role
Action
Shares
Price
Amount
Gutwerg Ori
10 Aug 2026
SVP, GENERICS
Sell
3,162
$77.00
$243.47K
Walsh Patrick D
13 May 2026
Director
Sell
10,000
$80.63
$806.30K
Gutwerg Ori
12 May 2026
SVP, GENERICS
Sell
2,772
$79.50
$220.37K
Rowland Thomas Andrew
12 May 2026
SVP, HEAD - ESTABLISHED BRANDS
Sell
459
$79.21
$36.36K
Lalwani Nikhil
11 May 2026
PRESIDENT & CEO
Sell
55,000
$77.57
$4.27M
Walsh Patrick D
11 May 2026
Director
Sell
3,973
$80.75
$320.82K
Rowland Thomas Andrew
11 Mar 2026
SVP, HEAD - ESTABLISHED BRANDS
Sell
4,772
$74.91
$357.47K
Walsh Patrick D
3 Mar 2026
Director
Sell
6,000
$74.23
$445.38K
Gutwerg Ori
3 Mar 2026
SVP, GENERICS
Sell
2,060
$76.50
$157.59K
TANNENBAUM RENEE P
5 Dec 2025
Director
Sell
1,800
$81.15
$146.07K
Gassert Chad
13 Nov 2025
SVP - CORP. DEV. & STRATEGY
Sell indirect
94
$88.00
$8.27K
Walsh Patrick D
13 Nov 2025
Director
Sell
8,643
$86.88
$750.90K
Gassert Chad
12 Nov 2025
SVP - CORP. DEV. & STRATEGY
Sell indirect
14,642
$89.07
$1.30M
Pera Antonio R
3 Sep 2025
Director
Sell
7,292
$94.94
$692.30K
Leonard Matthew J
25 Aug 2025
Director
Sell
2,528
$90.62
$229.09K
Davis Krista
22 Aug 2025
SVP, CHIEF HR OFFICER
Sell
1,763
$91.10
$160.61K
Shanmugam Muthusamy
21 Aug 2025
HEAD OF R&D, COO-NOVITIUM OPS
Sell indirect
52,988
$90.44
$4.79M
Pera Antonio R
20 Aug 2025
Director
Sell
5,421
$89.73
$486.43K
Shanmugam Muthusamy
20 Aug 2025
HEAD OF R&D, COO-NOVITIUM OPS
Sell indirect
47,012
$90.27
$4.24M
Leonard Matthew J
18 Aug 2025
Director
Sell
6,937
$88.17
$611.64K
Thoma Jeanne
18 Aug 2025
Director
Sell
14,675
$88.87
$1.30M
Thoma Jeanne
18 Aug 2025
Director
Sell
6,865
$89.76
$616.20K
Gassert Chad
15 Aug 2025
SVP - CORP. DEV. & STRATEGY
Sell indirect
20,000
$86.97
$1.74M
Shanmugam Muthusamy
15 Aug 2025
HEAD OF R&D, COO-NOVITIUM OPS
Sell indirect
52,990
$87.15
$4.62M
Walsh Patrick D
15 Aug 2025
Director
Sell
9,000
$89.05
$801.45K
Shanmugam Muthusamy
14 Aug 2025
HEAD OF R&D, COO-NOVITIUM OPS
Sell indirect
47,010
$89.48
$4.21M
HAUGHEY THOMAS
12 Aug 2025
Director
Sell
19,341
$85.93
$1.66M
Gutwerg Ori
12 Aug 2025
SVP, GENERICS
Sell
5,873
$86.53
$508.19K
Lalwani Nikhil
12 Aug 2025
PRESIDENT & CEO
Sell
56,960
$85.93
$4.89M
Rowland Thomas Andrew
12 Aug 2025
SVP, HEAD - ESTABLISHED BRANDS
Sell
4,975
$85.71
$426.41K
Gutwerg Ori
15 May 2025
SVP, GENERICS
Sell
881
$60.07
$52.92K
Mutz Christopher
14 May 2025
HEAD OF RARE DISEASE
Sell
4,000
$60.45
$241.80K
CAREY STEPHEN P.
17 Dec 2024
SVP & CFO
Sell
7,500
$55.79
$418.43K
Mutz Christopher
15 Nov 2024
HEAD OF RARE DISEASE
Sell
6,500
$57.70
$375.05K
Gutwerg Ori
5 Jun 2024
SVP, GENERICS
Sell
2,985
$67.00
$200.00K
CAREY STEPHEN P.
4 Jun 2024
SVP & CFO
Sell
5,000
$63.58
$317.90K
Mutz Christopher
21 May 2024
HEAD OF RARE DISEASE
Sell
2,000
$61.61
$123.22K
TANNENBAUM RENEE P
16 May 2024
Director
Sell
2,000
$63.87
$127.74K
Lalwani Nikhil
14 May 2024
PRESIDENT & CEO
Sell
16,669
$66.10
$1.10M
CAREY STEPHEN P.
11 Mar 2024
SVP & CFO
Sell
7,787
$65.55
$510.44K
Lalwani Nikhil
8 Mar 2024
PRESIDENT & CEO
Sell
16,292
$67.13
$1.09M
Marken James G.
7 Mar 2024
SVP OPS & PROD DEV
Sell
24,338
$66.37
$1.62M
Lalwani Nikhil
6 Mar 2024
PRESIDENT & CEO
Sell
28,965
$65.52
$1.90M
Mutz Christopher
5 Mar 2024
HEAD OF RARE DISEASE
Sell
5,000
$66.00
$330.00K
Pera Antonio R
4 Mar 2024
Director
Sell
7,000
$65.20
$456.40K
Davis Krista
15 Nov 2023
SVP, CHIEF HR OFFICER
Sell
2,622
$53.81
$141.09K
Mutz Christopher
10 Nov 2023
HEAD OF RARE DISEASE
Sell
3,000
$52.47
$157.41K
Shanmugam Muthusamy
29 Aug 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sell indirect
25,000
$63.37
$1.58M
Shanmugam Muthusamy
28 Aug 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sell indirect
25,000
$63.06
$1.58M
MERIDIAN VENTURE PARTNERS II LP
16 Aug 2023
10% owner
Sell
200,000
$58.50
$11.70M
CAREY STEPHEN P.
14 Aug 2023
SVP & CFO
Sell
17,639
$61.37
$1.08M
Lalwani Nikhil
11 Aug 2023
PRESIDENT & CEO
Sell
56,666
$57.75
$3.27M
MERIDIAN VENTURE PARTNERS II LP
1 Dec 2022
10% owner
Sell
200,000
$38.50
$7.70M
Marken James G.
15 Aug 2022
SVP OPS & PROD DEV
Sell
5,172
$37.79
$195.46K
Marken James G.
12 Aug 2022
SVP OPS & PROD DEV
Sell
12,894
$37.04
$477.61K
MERIDIAN VENTURE PARTNERS II LP
20 Aug 2019
10% owner
Sell
5,512
$68.18
$375.81K
MERIDIAN VENTURE PARTNERS II LP
19 Aug 2019
10% owner
Sell
2,067
$68.30
$141.18K
MERIDIAN VENTURE PARTNERS II LP
16 Aug 2019
10% owner
Sell
26,349
$68.09
$1.79M
MERIDIAN VENTURE PARTNERS II LP
15 Aug 2019
10% owner
Sell
9,315
$69.34
$645.90K
MERIDIAN VENTURE PARTNERS II LP
14 Aug 2019
10% owner
Sell
26,360
$69.89
$1.84M
MERIDIAN VENTURE PARTNERS II LP
13 Aug 2019
10% owner
Sell
20,821
$71.77
$1.49M
MERIDIAN VENTURE PARTNERS II LP
12 Aug 2019
10% owner
Sell
21,016
$71.45
$1.50M
MERIDIAN VENTURE PARTNERS II LP
9 Aug 2019
10% owner
Sell
19,860
$71.70
$1.42M
Marken James G.
17 May 2019
SVP Ops & Prod Dev
Sell
8,907
$70.67
$629.46K
PRZYBYL ARTHUR
15 May 2019
President and CEO
Sell
14,633
$69.25
$1.01M
Marken James G.
14 May 2019
SVP Ops & Prod Dev
Sell
4,917
$70.31
$345.71K
PRZYBYL ARTHUR
14 May 2019
President and CEO
Sell
5,772
$70.45
$406.64K
Schrepfer Robert W
13 May 2019
SVP - New Bus Dev & Spec Sales
Sell
2,409
$71.13
$171.35K
PRZYBYL ARTHUR
13 May 2019
President and CEO
Sell
9,595
$71.10
$682.20K
MARSHBANKS TRACY
16 May 2018
Director
Sell indirect
25,706
$62.40
$1.60M
MARSHBANKS TRACY
15 May 2018
Director
Sell indirect
7,024
$62.05
$435.84K
MARSHBANKS TRACY
14 May 2018
Director
Sell indirect
5,506
$62.35
$343.30K
MARSHBANKS TRACY
10 May 2018
Director
Sell indirect
24,229
$62.03
$1.50M
MARSHBANKS TRACY
10 May 2018
Director
Sell indirect
17,685
$62.14
$1.10M
MARSHBANKS TRACY
9 May 2018
Director
Sell indirect
20,517
$62.05
$1.27M
MARSHBANKS TRACY
18 Apr 2018
Director
Sell indirect
33,200
$62.09
$2.06M
RAYNOR DANIEL
19 Mar 2018
Director
Sell indirect
5,313
$60.62
$322.07K
RAYNOR DANIEL
15 Mar 2018
Director
Sell indirect
1,902
$61.50
$116.97K
RAYNOR DANIEL
14 Mar 2018
Director
Sell indirect
1,919
$62.02
$119.02K
PRZYBYL ARTHUR
14 Mar 2018
President and CEO
Sell
10,000
$62.03
$620.30K
MARSHBANKS TRACY
14 Mar 2018
Director
Sell indirect
1,912
$63.10
$120.65K
RAYNOR DANIEL
13 Mar 2018
Director
Sell indirect
4,117
$62.59
$257.68K
RAYNOR DANIEL
13 Mar 2018
Director
Sell indirect
14,000
$61.81
$865.34K
PRZYBYL ARTHUR
13 Mar 2018
President and CEO
Sell
6,525
$62.63
$408.66K
PRZYBYL ARTHUR
13 Mar 2018
President and CEO
Sell
23,475
$61.52
$1.44M
MARSHBANKS TRACY
12 Mar 2018
Director
Sell indirect
12,269
$63.03
$773.32K
Showing 250 of 264 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 439
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 123
Sales straight out of an exercise 26
Sales at will 89
Transactions with no price 0
Shares from compensation/vesting 4,962,594
Sales filed before the plan box existed 37
History held since 16 Nov 2016